ABBV AbbVie Inc

By Dave Sebastian

AbbVie Inc.'s Allergan Aesthetics will buy Soliton Inc. for about $550 million including debt, giving Allergan Aesthetics Soliton's Rapid Acoustic Pulse platform for improvement in appearance of cellulite in the buttocks and thighs.

At $22.60 a share in cash, the deal values Soliton at a 26% premium over its closing price Friday. The acquisition supports Allergan Aesthetics' body-contouring treatment portfolio, the companies said Monday.

Resonic, the Rapid Acoustic Pulse device, has received a Food and Drug Administration clearance for use in conjunction with laser for tattoo removal, the companies said.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

May 10, 2021 09:07 ET (13:07 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.